MedTrace Logo

An Evaluation of the Effect of the Erchonia Laser for Non-invasive Reduction of Submental Fat

NCT05954065 · Status: COMPLETED · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2025-08-29

Study results available
· View outcomes & findings →

Summary

The purpose of this clinical study is to determine the effectiveness of the Erchonia® CFL (manufactured by Erchonia Corporation (the Company), in providing noninvasive fat reduction in the submental area.

Conditions

Interventions

DEVICE

Erchonia CFL Laser

405nm violet and 520nm green laser light therapy.

Sponsors & Collaborators

  • Erchonia Corporation

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-12
Primary Completion
2024-05-31
Completion
2024-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05954065 on ClinicalTrials.gov